September, 2024

September has been an exciting and eventful month for conferences across Canada, and Medlior was thrilled to contribute to the important discussions on real-world evidence, value based-pricing, and healthcare innovation. These events offered great opportunities to build collaborations and drive meaningful improvements in healthcare.

Keep reading to explore the key insights and takeaways from the conferences Medlior participated in this month!

Canada’s Drug Agency Symposium 2024

Medlior was delighted to attend Canada's Drug Agency 2024 Sympoisum, where pivotal discussions around reimbursement and healthcare system sustainability took center stage. Key highlights included deep dives into real-world evidence (#RWE) in reimbursement decisions, the evolving role of health technology assessment (#HTA) in policymaking, and the importance of patient-centric approaches in health technology reviews. The conference provided invaluable insights into the initiatives underway in Canada, such as post-market drug evaluations, drugs for rare diseases, and time-limited recommendations, to name a few. These sessions sparked meaningful conversations on how innovative data-driven strategies, like those championed by Medlior, can enhance the decision-making process and ultimately improve patient care.

At the symposium CDA announced the release of their Inventory of Rare Disease Registries. Medlior was delighted to support CDA with the preparation of this important resource - click here.

BioAlberta - AGM and Health and Life Sciences Showcase

Medlior is proud to announce that our President, Tara Cowling, has been welcomed as a new member of the BioAlberta Board of Directors. Tara is honored to contribute to the continued growth and success of this vital organization.

Additionally, Tara had the pleasure of attending BioAlberta’s 2024 Health and Life Sciences Showcase in Calgary on September 26th. This event brought together leading voices from Alberta’s dynamic biotechnology sector and highlighted cutting-edge innovations in health technologies, life sciences, and transformative applications in patient care. Key presentations focused on advancements in precision medicine, the role of artificial intelligence in healthcare, and exciting opportunities for collaborative research within Alberta’s thriving health ecosystem. The showcase provided an excellent opportunity for networking and exploring partnerships, and we are eager to apply these insights as Medlior continues to drive innovation through data-driven healthcare solutions.

Congratulations to Jaspreet K Grewal, MBA , CEO and co-founder of AxialBridge on receiving the Vista Award from BioAlberta! Your dedication and contributions to the life sciences industry in Alberta are truly inspiring. Your latest achievement of bringing a new partnership opportunity for BioAlberta with the NIHR (National Institute for Health and Care Research) is incredibly exciting for all Alberta life sciences companies looking for global reach!

Clinical Research Association of Canada (CRAC) - Alberta Launch

During Life Sciences Week, Medlior was also proud to support the Clinical Research Association of Canada’s (CRAC) Alberta launch event. This significant event brought together clinical research professionals, healthcare leaders, and innovators from across the province. A keynote address by the Alberta Minister of Technology and Innovation, Nate Glubish , highlighted Alberta’s unique role as a hub for cutting-edge life sciences innovation. The event also featured a presentation by Medlior’s President, Tara Cowling , who spoke on the transformative power of real-world evidence (#RWE) in healthcare. A highlight of the evening was a panel discussion with leading experts in RWE and how patient data can be better leveraged in healthcare. The panelists included Kun Shi, PhD, MBA from Janssen Canada, Dr. Tyler Williamson from 加拿大卡尔加里大学 , Paula Robson and Linda Watson of Alberta Health Services .

The launch underscored Alberta’s leadership in advancing clinical research and provided valuable opportunities for collaboration—perfectly aligning with Medlior’s mission to leverage Alberta’s world-class health system data to drive better patient outcomes.

TOWWERS Institute - Action Plan Meeting

Join Medlior for an impactful event hosted by the TOWWERS Institute , a Canadian nonprofit co-founded by Julie Frappier , Ursula Mann and Tara Cowling .

TOWWERS Institute is dedicated to accelerating patient access to innovation! This dynamic gathering will bring together patients, providers, payers, policymakers, and industry leaders to drive real change by shaping patient-centric, value-based, and affordable healthcare solutions.

The event will feature the introduction of the TOWWERS Institute, insights on value-based pricing projects, and the unveiling of an exclusive platform for capturing real-world data (#RWD). Join us on November 26, 2024, at the Toronto Congress Centre—complimentary registration is available now!

Click here for Registration and more information!

Final Thoughts

Thank you for taking the time to catch up with Medlior’s latest developments. We’re thrilled to be making strides in real-world evidence research and to have the opportunity to share our progress with you. As always, we’re here to support your research endeavors—whether through our expanding RWR platform, tailored database mapping services, or new offerings like Rapid Insights?. Don’t hesitate to reach out to see how we can support your evidence generation activities.

Stay tuned for more exciting updates next month!

Many thanks,

Tara

Founder and President

Medlior Health Outcomes Research Ltd.

Established in 2008